HCPlive (4/5, Walter) reports researchers have shown “a complex relationship between post-traumatic stress disorder (PTSD) symptoms and drinking alcohol to cope with the symptoms for men in the military.” For the study, investigators “used interview data from 11,474 [participants] who reported at least one lifetime traumatic experience from the National Epidemiologic survey on Alcohol and Related Conditions (NESARC), a face-to-face interview study of a nationally representative sample of adults living in the US between 2004-2005.” The study “compared trauma-exposed men without combat experience to men with military combat experience to identify who would be more likely to endorse drinking alcohol to cope with their PTSD symptoms.” The findings were published online March 17 in the Journal of Dual Diagnostics.

Related Links:

— “New Study Shows Alcohol, PTSD Relationship in Veterans “Kenny Walter, HCPlive, April 5, 2021

The AP (4/5, Johnson) reports the FDA approved Supernus Pharmaceuticals’ Qelbree (viloxazine) for the treatment of children with AD/HD. Unlike most alternatives, “Qelbree is not a stimulant or a controlled substance, making it harder to abuse than older drugs,” which has been an issue for other AD/HD drugs. The AP adds that “viloxazine was sold as an antidepressant in Europe for several decades, but was never approved by the FDA.”

The Hill (4/5, Choi) reports viloxazone is the first new drug approved by the FDA to treat children with AD/HD in more than a decade.

Related Links:

— “FDA Approves New Drug For Children With AD/HD “Linda A. Johnson, AP, April 5, 2021

MedPage Today (4/2, Gever) reported, “Most adults who reported using e-cigarettes indicated that they would like to stop, federal survey data indicated, but ratings of the strength of intention varied by their past histories with tobacco and, in general, were not especially high.” The researchers found that “among 1,988 self-identified e-cigarette users in wave 4 (conducted 2016-2018) of the Population Assessment of Tobacco and Health (PATH) survey, 1,194 (60.1%) said they planned to quit,” although “respondents’ mean ‘level of interest in quitting,’ which they ranked on a 10-point scale (with 10 the strongest), was just 3.9 overall (95% CI 3.8-4.1).” The findings were published in a JAMA Network Open research letter.

Related Links:

— MedPage Today (requires login and subscription)

Healio (4/2, Gramigna) reported, “Separation anxiety may significantly predict suicidal thoughts among patients with mood and anxiety disorders, according to study results published in Journal of Clinical Psychiatry.” In the study, “the researchers sought to assess the link between both childhood and adult separation anxiety and suicide risk measures among 509 consecutive psychiatric outpatients with anxiety and mood disorders according to DSM-IV criteria.”

Related Links:

— “Separation anxiety significantly predicts suicidal thoughts in mood, anxiety disorders “Joe Gramigna, Healio, April 2, 2021

Psychiatric News (4/2) reported, “Children who have a parent with bipolar disorder are more likely to develop attention-deficit/hyperactivity disorder (ADHD) during their preschool years than children with no family history of bipolar disorder, reports a study in Journal of the American Academy of Child and Adolescent Psychiatry.” In addition, the study “found that these children were more likely to develop symptoms of bipolar disorder as they grew older.”

Related Links:

— “Children of Parents With Bipolar Disorder at Risk of ADHD and Early Onset Bipolar, Study Suggests, Psychiatric News, April 2, 2021